CMS Announces Manual Wheelchair Accessories are Permanently Exempt from the Competitive Bidding Program

Published in Government Relations on July 29, 2021

CMS announced today that manual wheelchair accessories will be permanently exempt from future competitive bidding programs.

As printed in the CMS fact sheet:

“CMS is finalizing an exclusion from fee schedule adjustments based on information from the DMEPOS Competitive Bidding Program (CBP) for wheelchair accessories (including seating systems) and seat and back cushions furnished in connection with group 3 or higher complex rehabilitative power wheelchairs. We are also extending this fee schedule adjustment exclusion to wheelchair accessories (including seating systems) and seat and back cushions furnished in connection with complex rehabilitative manual wheelchairs. Additionally, we are modifying the regulatory definition of “item” under the DMEPOS CBP at 42 CFR 414.402 to exclude complex rehabilitative manual wheelchairs and certain other manual wheelchairs and related accessories when furnished in connection with these wheelchairs from the DMEPOS CBP, as required by section 106(a) of the 2020 Further Consolidated Appropriations Act.”

https://www.cms.gov/newsroom/fact-sheets/fiscal-year-fy-2022-inpatient-rehabilitation-facility-irf-prospective-payment-system-pps-final-rule

“This is indeed good news for providers of complex rehab technology. While this is big win for Complex Rehab Technology providers, it is huge for end users. This will result in the overall reduction of healthcare cost with proper seating and positioning for beneficiaries,” said Greg Packer, president of U.S. Rehab.

In 2017, legislation passed omitting power wheelchair accessories from CMS’s competitive bid program. But manual wheelchair accessories were not included in this legislation and remained in the competitive bid program. 

To address this gap, in December of 2019, Congress passed language from H.R. 1865 to make clear the intent was for both power and manual wheelchair accessories to be treated the same. The legislation included a provision suspending CMS’s application of Medicare’s competitive bid program pricing until June 30, 2021, allowing time for CMS to take the same permanent action. It was then extended 90 days.

Many thanks to Rep. John Larson (D-CT) and Rep. Lee Zeldin (R-NY) who for years have been our primary supporters of this exemption with legislative efforts and letters to CMS. We also want to thank all who reached out asking their legislators to support these efforts.


TAGS

  1. competitive bidding
  2. complex rehab
  3. vgm government

From Our Experts

Shutdown Ends, Telehealth Prevails as Pres. Trump Signs Funding Bill thumbnail Shutdown Ends, Telehealth Prevails as Pres. Trump Signs Funding Bill The four-day partial federal government shutdown officially ended on Feb. 3, 2026, after President Donald Trump signed a $1.2 trillion funding package that reopens most federal agencies and restores key programs. CMS Releases New HCPCS thumbnail CMS Releases New HCPCS The Centers for Medicare & Medicaid Services (CMS) released an update adding eight new oxygen HCPCS codes to the Required Face-to-Face and Written Order Prior to Delivery List and adding five new orthoses and two HCPCS codes to the Required Prior Authorization List. The changes go into effect April 13, 2026. Meet the Candidates: Rep. Ashley Hinson Visits VGM During U.S. Senate Campaign thumbnail Meet the Candidates: Rep. Ashley Hinson Visits VGM During U.S. Senate Campaign Waterloo, Iowa — On Wednesday, VGM Group welcomed employees, local DME suppliers, and community guests for the latest installment of its Meet the Candidates series. The featured guest was Rep. Ashley Hinson (R-IA), who currently represents Iowa's 2nd Congressional District and is now running for the U.S. Senate following Sen. Joni Ernst's decision not to seek reelection in 2026. Grassroots Accountability Program Wants YOU! Become a DMEPOS Advocate thumbnail Grassroots Accountability Program Wants YOU! Become a DMEPOS Advocate Are you interested in politics or curious about how government really works behind the scenes The Grassroots Accountability Program (GAP) is a great opportunity to expand your civic knowledge, build meaningful relationships with your state and federal legislators, and make a direct impact on the future of the DMEPOS industry. CMS Issues FAQ On DMEPOS Competitive Bidding Program thumbnail CMS Issues FAQ On DMEPOS Competitive Bidding Program The Centers for Medicare and Medicaid Services (CMS) has issued a DMEPOS CBP Frequently Asked Questions (FAQ) providing clarification on several points of the next round. Medicare Advantage Plans Are in Flux: What Providers Should Know thumbnail Medicare Advantage Plans Are in Flux: What Providers Should Know As reported by HME News WASHINGTON – Medicare Advantage (MA) plans will face new restrictions in 2026 that could force insurers to rethink their business models, according to payer relations experts. While these changes don't directly impact home medical equipment (HME) providers today, they could influence future plan design and reimbursement strategies. BOC Reinstated As Approved Accrediting Organization thumbnail BOC Reinstated As Approved Accrediting Organization As reported by HME News: Court grants company's motion for temporary restraining order against CMS OWINGS Mills, MD.—The Board of Certification/Accreditation (BOC) has been reinstated as an approved accrediting organization (AO) in all but four states, the company has announced. Click here to read the full article from HME News. The federal court has granted a temporary restraining order (“TRO”) in favor of BOC…thereby restoring BOC as an accrediting organization in all states except N DMEPOS Bills Gaining Momentum thumbnail DMEPOS Bills Gaining Momentum Fresh off a great House Energy & Commerce Health Sub-Committee hearing, now is the perfect time to reach out to your representative(s) and ask them to support the DMEPOS Relief Act, H.R. 2005; Choices for Increased Mobility Act of 2025, H.R. 1703; and the Supplemental Oxygen Access Reform Act of 2025, H.R. 2902.